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Abstract 
The widely used genetic pleiotropic analysis of multiple phenotypes are often designed for 
examining the relationship between common variants and a few phenotypes. They are not suited 
for both high dimensional phenotypes and high dimensional genotype (next-generation 
sequencing) data. To overcome these limitations, we develop sparse structural equation models 
(SEMs) as a general framework for a new paradigm of genetic analysis of multiple phenotypes. 
To incorporate both common and rare variants into the analysis, we extend the traditional 
multivariate SEMs to sparse functional SEMs. To deal with high dimensional phenotype and 
genotype data, we employ functional data analysis and the alternative direction methods of 
multiplier (ADMM) techniques to reduce data dimension and improve computational efficiency. 
Using large scale simulations we showed that the proposed methods have higher power to detect 
true causal genetic pleiotropic structure than other existing methods. Simulations also 
demonstrate that the gene-based pleiotropic analysis has higher power than the single variant-
based pleiotropic analysis. The proposed method is applied to exome sequence data from the 
NHLBI’s Exome Sequencing Project (ESP) with 11 phenotypes, which identifies a network with 
137 genes connected to 11 phenotypes and 341 edges. Among them, 114 genes showed 
pleiotropic genetic effects and 45 genes were reported to be associated with phenotypes in the 
analysis or other cardiovascular disease (CVD) related phenotypes in the literature. 
 
 
 
 
Introduction 
        In the past several years, a large number of statistical methods for association analysis of 
both qualitative and quantitative traits with next-generation sequencing data were developed.1-14 
Most genetic analyses of quantitative traits focus on association analysis of a single trait, 
analyzing each phenotype individually and independently.15 However, multiple phenotypes are 
correlated. For example, metabolism of lipoproteins involves cholesterol, triglycerides, very low 
density lipoproteins (VLDL), low density lipoproteins and high density lipoproteins. These 
multiple traits are dependent. The integrative analysis of correlated phenotypes often increase 
statistical power to identify genetic associations.16,17 The association analysis of multiple 
phenotypes is expected to become popular in the near future.18 
  Three major approaches are commonly used to explore association of genetic variants 
with multiple correlated phenotypes: multiple regression methods, integration of p values of 
univariate analysis, and dimension reduction methods.16  Despite their differences in selection of 
specific methods for estimation, all these estimation methods share the following common 
features. First, many methods were designed for common variants and hence may not be 
appropriate for rare ones. Second, the results of all these analyses are difficult to interpret. They 
do not provide information to indicate which phenotypes the genetic variants are significantly 
associated.15 Third, all these methods estimate the effect of the genetic variant on each phenotype 
individually and do not explore the dependency patterns of genetic effects among the phenotypes 
and do not provide a detailed characterization of the relationships among the genetic effects. 
Fourth, all these estimations only estimate the effects of the genetic variants on the phenotypes. 
However, the genetic effects can be classified into three types of effects: direct, indirect and total 
effects. These methods are unable to reveal mechanisms underlying the genetic structures of 
multiple phenotype association analysis.19 The direct effect is the measurement of the influence 
of a genetic variant on a phenotype that is not mediated by any other phenotypes in a system. 
The indirect effect of a genetic variant measures the sensitivity of a phenotype to change of a 
genetic variant that is mediated by at least one intervening variable (phenotype). The total effect 
is the sum of the direct and indirect effects. The most popular multivariate association methods 
are lack of ability to decompose total effect into direct effect and indirect effect and ignore 
indirect effects through other mediating phenotypes and risk factors. Therefore, they cannot 
discover how the effect of the genetic variant on the phenotype is mediated by other phenotypes 
and the effect path from the initially affected phenotype by the genetic variant through a number 
of mediating phenotypes to the targeted phenotype. Pleiotropic effect is a context dependent 
genetic effect and plays an important role in multivariate trait association studies and evolution 
analysis.20 The pleiotropic effect of a specific genetic variant on multiple phenotypes may be due 
to either direct contribution of the genetic variant to the multiple phenotypes or phenotype 
correlations (mediations). The multivariate trait association studies cannot distinguish the paths 
connecting multiple phenotypes and genetic effects.21 
In the past several years, there have been increasing interests in modeling the complex 
structures among phenotypes, risk factors and genotypes which are referred to as the genotype-
phenotype networks and therefore overcome these limitations. Current methods for inference of 
genotype-phenotype networks can be classified into two categories: whole network scoring 
methods and local analysis methods.22-29 Network scoring approaches assign a score to the 
network model for measuring how well the network fits the data and develop algorithms to 
search the network with the best score. Local analysis methods analyze small sets of variables 
that are pieced together into networks from multiple causality tests between variables.  
     One of network scoring methods is structure equations that can be used as a tool to model the 
complex network structures among phenotypes, risk factors and genotypes.19-21,30-32 A graphical 
model in which the variables are represented as nodes and the relationships between variables are 
represented by edges between the nodes can be used to model the genotype-phenotype networks. 
Structural equations can generate biological interpretations of relations among variables and 
uncover the mechanism structure underlying phenotypic and genotypic relationships. To date, in 
applications of the structural equation model (SEM) in quantitative genetics, the causal structure 
was assumed to be known as a priori, or partially specified, thereby allowing selection of the 
causal structure for a small set of variables from the data.21 There are two major approaches to 
estimate the causal structure from the data. One approach is based on the conditional 
independence and the notion of Markov equivalence of directed acyclic graphs (DAGs).33 DAGs 
encode causal structure. However, a DAG is not, in general, identifiable from observational data. 
Conditional independence only determines the skeleton of the DAG which is the undirected 
graph of the DAG by removing its directions of all edges, and the v  structure of the DAG where 
two nodes are directed to a common node (collider).34 A number of algorithms such as PC-
algorithms have been used to estimate the equivalence class of DAGs.35 A second approach is to 
use the notion of ‘sparse’ and develop sparse SEMs for estimating the causal structures.36 By 
incorporating the penalized constraints of the parameters into the likelihood function to enforce 
the network sparsity, we could estimate the causal structure.  Coordinate ascent algorithms are 
often used to maximize the penalized likelihood functions.  
Despite their successful application to joint analysis of genetic architecture and causal 
phenotype networks, current approaches often demand intensive computations and are lack of 
efficient computational algorithms for implementing penalization of network structure 
parameters. Therefore, they cannot be used for large-scale causal inference. Most current 
approaches are designed for common variants and are difficult to be applied to NGS data. The 
purpose of this paper is to overcome these limitations. We first develop novel functional SEMs 
where exogenous genotype profiles across a genomic region or a gene are represented as a 
function of the genomic position for genetic association analysis of multiple quantitative traits 
which is referred to as multivariate QTL analysis. The functional SEMs for multivariate QTL 
analysis consist of three components. The first component is a phenotype network that is 
modeled as a directed graph. The second component is a genotype network that is represented as 
an undirected graph. The third component is connections between the genotype network and 
phenotype network with direction from genotype nodes to phenotype nodes. To make the 
network sparse and reduce the burden of computations, we develop the novel sparse SEMs for 
genotype-phenotype networks and an efficient computational algorithms based on alternative 
direction methods of multiplier (ADMM) to search the causal structure and estimate the 
parameters.37,38 We will estimate the direct, indirect and total effects of the genetic variants on 
the phenotypes using estimated directed graph and intervention calculus39 and explore the 
relationships between direct, indirect and total effects estimated from SEMs and the genetic 
effects estimated from the traditional simple regressions and multiple regressions. Finally, the 
sparse SEMs are applied to exome sequence data from the NHLBI’s Exome Sequencing Project 
(ESP) with 11 phenotypes. A program for implementing the developed sparse SEMs for 
quantitative genetic analysis with multiple phenotypes can be downloaded from our website 
http://www.sph.uth.tmc.edu/hgc/faculty/xiong/index.htm. 
 
 
Material and Methods 
         Multivariate quantitative trait association analysis can be investigated by phenotype-
genotype networks, which can be represented as a graph. Phenotypes, covariates such as age, sex, 
race, and SNPs are variables. Variables are represented as nodes in the graph. We assume that 
causal relationships among phenotypes exist. Therefore, a phenotype network is represented by a 
directed graph. A directed edge between two nodes indicates the causal relationship between 
them. Since SNPs do not have causal relationships among them, a genotype network is 
represented as an undirected graph. An edge between two nodes in the genotype network 
indicates their correlation. Since all SNPs and covariates may cause changes in phenotypes, the 
phenotype network and genotype network are connected by edges directed from covariates and 
SNP to the phenotypes.  The phenotypes and connections between phenotypes, covariates and 
SNPs can be modeled by structural equations. The genotype network can be leant by graphical 
LASSO (GLASSO),39 here we didn’t focus on genotype network in this paper. An example of 
phenotype-genotype network is shown in Supplementary Figure S1.  
SEMs for Multivariate Association Analysis 
The SEMs offer a general statistical framework for inferring phenotype networks and 
connections between genotypes and phenotypes. Assume that n individuals are sampled. We 
consider M phenotypes that are referred to as endogenous variables. We denote the n
observations on the M endogenous variables by the matrix ],...,,[ 21 MyyyY  , where 
T
niii yyy ],...,[ 1  is a vector of collecting n observation of the endogenous variable i . Covariates, 
genetic variants as exogenous or predetermined variables are denoted by ],...,[ 1 KxxX  where 
T
niii xxx ]...,[ ,1 .Similarly, random errors are denoted by ],,...,[ 1 MeeE  where we assume 
0][ ieE and ni
T
ii IeeE
2][  for .,...,1 Mi   The linear structural equations for modeling 
relationships among phenotypes and genotypes can be written as38 
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where the  ’s and  ’s are the structural parameters of the system that are unknown.  In matrix 
notation the SEMs (1) can be rewritten as 
0 EXBY ,          (2) 
where ],...,[ 1 M , 
T
Miii ],...,[ 1  , 
T
KiiiM BBBB ],...,[],,...,[ 11  .  
We assume that the random errors in the structural equations are independent and 
uncorrelated with exogenous variables. We apply the sparsity penalty to each equation to ensure 
that the sparse SEMs are identifiable. 
Two-Stage Least Square Estimates of the Parameters in the SEMs 
The ordinary least squares estimator is biased and inconsistent for the parameters of 
structural equations. To ensure the consistent estimates of the parameters in the SEMs, we use a 
generalized least square method that can be interpreted as a two-stage least square estimate 
method to estimate the parameters in the SEMs.38 
Recalling that iy is the vector of observations of the variable i , let iY be the observation 
matrix Y after removing iy from it and i be the parameter vector i after removing the 
parameter ii . The i th equation: 
0 iii eXBY  
can be rewritten as 
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where    TTiTiiii BXYW   , . 
Multiplying by the matrix TX on both sides of equation (3), we obtain 
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It is known that 
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The generalized least square estimate iˆ is given by 
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The generalized least square estimate iˆ can be interpreted as a two-stage least square estimate.
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Equation (5) can be reduced to 
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Therefore, if iW in equation (3) is replaced by iWˆ , equation (6) can be interpreted as that in the 
second stage, iy is regressed on iYˆ  and X to obtain estimate iˆ .  
Sparse SEMs and Alternating Direction Method of Multipliers 
In general, the genotype-phenotype networks are sparse. Therefore,  and B are sparse 
matrices. In order to obtain sparse estimates of  and B , the natural approach is the 
1l -norm 
penalized regression of equation (4). Using weighted least square and 
1l -norm penalization, we 
can form the following optimization problem: 
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The size of the genotype-phenotype network may be large. An efficient alternating direction 
method of multipliers (ADMM)37 is used to solve the optimization problem (7). The procedure 
for implementing ADMM is given below (more detailed descriptions are provided in Appendix 
A). 
Algorithm: 
For Mi ,...,1  
Step 1. Initialization 
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Carry out steps 2,3 and 4 until convergence 
Step 2. 
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Under some assumptions convergence of ADMM can be proved.37 In practice, although it can 
be slow to converge to high accuracy, ADMM converges to modest accuracy within a few tens 
of iterations. When large-scale problems and parameter estimation problems are considered, 
modest accuracy is sufficient. Therefore, ADMM may work very well for structure and 
parameter estimation in the genotype-phenotype networks.  
Most of the elements of matrices  and B are equal to zero. The 1l regularized Lasso 
for the two stage least squares approach and ADMM algorithms are expected to shrink most of 
the coefficient matrices and B toward zero, yielding sparse network structures. The sparsity-
controlling parameter   will be estimated via cross validation or set by users to get reasonable 
results. 
Sparse Functional Structural Equation Models for Phenotype and Genotype Networks 
In the previous section, the SEMs carry out variant by variant analysis. However, the 
power of the traditional variant-by-variant analytical tools that are mainly designed for common 
variants, for association analysis of rare variants with the phenotypes will be limited. Large 
simulations have shown that combining information across multiple variants in a genomic region 
of analysis will greatly enhance power to detect association of rare variants.9 To utilize multi-
locus genetic information, we propose to use a genomic region or a gene as a unit in multiple 
trait association analysis and develop sparse functional structural equation models (FSEMs) for 
construction and analysis of the phenotype and genotype networks.  
     Let t be a genomic position. Define a genotype profile )(txi   of the i-th individual as 
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whereQ  and q  are two alleles of the marker at the genomic position t, )(tPQ and )(tPq are the 
frequencies of the alleles Q  and q , respectively. Suppose that we are interested in k  genomic 
regions or genes [ ],, jj ba denoted as kjT j ,...,2,1,  . We consider the following functional 
structural equation models: 
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where  )(tij are genetic effect functions.  
For each genomic region or gene, we use functional principal component analysis to 
calculate principal component function.14 We expand kjNntxnj ,...,2,1,,...,1),(  in each 
genomic region in terms of orthogonal principal component functions: 
,,...,1,)()(
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where jjl Llkjt ,...,1,,...,1),(  are the l -th principal component function in the j -th genomic 
region or gene and ijl  are the functional principal component scores of the i -th individual. 
      Let   be a matrix collection of all functional principal component scores, the parameter matrix
B can be defined as that in Appendix B, matricesY and  can be defined as that in the previous section. 
The structural functional equations can be reduced in terms of functional principal component scores 
(Appendix B): 
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Then, the sparse FSEMs are transformed to 
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The ADMM algorithms for solving the sparse FSEMs are the same as that in the previous section 
if the matrix X is replaced by a functional principal component score matrix   (Appendix B).  
Effect Decomposition and Estimation 
To make this paper self-contained, we introduce basic concepts and methods for 
decomposition and estimation of the effects. In the genotype-phenotype network analysis we are 
interested in estimation of effects of genetic variants on phenotypes, which is referred to as 
genetic effects and effects of treatment on phenotypes. All genetic effects and treatment effects 
can be decomposed as total (causal), direct effects and indirect effects. Distinction between total, 
direct and indirect effects are of great practical importance in genetic association analysis.40 The 
total effect measures the changes of response variable Y (phenotype) would take on the value y
when variable X is set to x  by external intervention. Direct effect is defined as sensitivity of Y
to changes in X while all other variables in the model are held fixed. Indirect effect is to measure 
the portion of the effect which can be explained by mediation alone, while inhibiting the capacity 
of Y to respond to X .41  The total effect is equal to the summation of direct and indirect effects.  
      Given a directed graph model G , one can compute total effects using intervention 
calculus.34,42 Suppose that the expected value of a response variable Y , after X is assigned value 
x by intervention is denoted by )](|[ xXdoYE  . The total effect is defined as 
)](|[ xXdoYE
x



.        (10) 
  Note jX  is called a parent of X in G if there is a directed edge XX j  . Let xpa denote 
the set of all parents of X in G . In the linear SEMs, we assume that ]pa ,|[ xXYE  is linear in 
X and xpa : 
x
T
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When a directed graph is given, it is easy to calculate total effect.42 Assume that there are 
k directed paths from X to Y and ip are the product of the path coefficients along the i -th path. 
The total effect of X on Y is then defined as 
k
i i
p
1
. As shown in Figure S2, the total effect of  
X on Y is acdhbdhag  . By its definition, direct effect measures the sensitivity of Y to 
changes in X while all other variables in the model are held fixed. In other words, all links from  
X toY other than the direct link will be blocked. As a consequences, the direct effect is equal to 
the path coefficient from X to Y . In the linear SEMs, the indirect effect of X on Y mediated by 
M is equal to the sum of the products associated with directed paths from X to Y through M .42 
In Figure S2, there is no direct effect from X to Y . The indirect effect of X on Y which is 
mediated by B and D is equal to bdh .  
In the SEMs for genotype-phenotype networks, since all SNPs only form undirected 
graph and there are no directed links between SNPs although we can observe linkage (or 
correlation) between SNPs; SNPs in the genotype-phenotype networks do not have parents. The 
total effect of SNP X on Y is the regression coefficient   of the following linear regression: 
xxXdoYE   )]( |[ , 
which is a simple regression of Y on X . This indicates that the traditional simple regression for 
association studies captures the total effect of a genetic variant on a phenotype.  
If we include environments and risk factors such as smoking and obesity in the model 
and want to evaluate the effects of the environments and risk factors on the phenotype, these 
variables play mediating roles and will also be taken as phenotypes. We denote these mediating 
phenotypes by 
MEY . Since genetic variants, and other risk factors and phenotypes will affect the 
mediating phenotypes, the mediating phenotypes in the graphics may have parents. Their parents 
are denoted by S . Total effect of the mediation phenotype on the target phenotype is calculated 
by 
pa
T
MEpapaMEME xyxXyYdoYE   )],( |[ ,    (12) 
where   is the total effect of the mediation phenotype 
MEY on the target phenotype Y . In this 
case, a simple regression of Y on
MEY can no longer be used to measure the total effect of the 
mediation phenotype 
MEY on the target phenotype Y . To observe this, we simulated 1,000 
individuals with the SEM as shown in Figure S3. Each variable has a noise term distributed as 
)1,0(N . The total effect of the mediation phenotype 
MEY on the target phenotype Y is 3.5. We 
obtain the simple regression: 
MEYY 85.539.1  . 
It is clear that the coefficient of the simple regression is 5.85. This value is far away from 
the total effect 3.5. However, using equation (12) we obtain 
XYY ME 85.554.3  , 
where the regression coefficient 3.54 measured the total effect of the mediation phenotype 
MEY
on the target phenotype Y . 
Test Statistics for Path Coefficients 
 Testing connection between the j -th gene and the i -th phenotype in the genotype-
phenotype network, we formally investigate the problem of testing the coefficient of the path 
directed from the j - th gene to the i -th phenotype: 
 0)(:0 tH ji ,      ],0[ jTt                                                             (13) 
against 
                   0)(: tH jia  . 
If the coefficient function of path or genetic effect function )(tji  is expanded in terms of the 
principal component functions: 
                                               
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then testing the null hypothesis H0 in equation (13) is equivalent to testing the hypothesis: 
                            g , 0:0 jigbH .                                                          (14) 
The path coefficients jigb can be estimated by solving problems (8) and (9). Let 
T
jiGjiji bbb ],...,[
ˆ
1 .  The covariance matrix of the vector of the estimators of path coefficients for 
the i -th equation is given by38 
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Let  i  be the submatrix that corresponds to jib in the matrix iˆ .  Define the statistic for testing 
the directed connection from the j -th gene to  the i -th phenotype as 
jii
T
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ˆˆ 1 .         (17) 
Under the null hypothesis of no association 0:0 jibH , gT is asymptotically distributed as a 
central 2
)(G distribution where G is the number of functional principal components in the 
expansion of )(tji . 
For testing a single parameter or single variant’s path coefficient in the SEMs, the l -th 
parameter of the i -th equation, the statistic is given by 
)ˆvar(
ˆ 2
il
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where )ˆvar( il  is the l -th diagonal element of the matrix iˆ . Under the null hypothesis 
0:0 ilH , cT  is asymptotically distributed as a central 
2
)1( distribution. 
Results 
Model Evaluation by Simulations 
We evaluated the performance of the sparse SEM approach for genetic analysis of 
multiple quantitative traits in simulation studies of a genotype-phenotype network where SNP-
based simulations and gene-based simulations were considered. The simulations were carried out 
for common variants, rare variants and both common and rare variants. In the SNP-based 
simulations, the SNPs consisted of 30 common variants, 30 rare variants and 10 common and 20 
rare variants, respectively. In the gene-based simulations, a total of 10 genes (10 SNPs for each 
gene) were included where we also considered 3 scenarios: genes consisted of 1) only common 
variants, 2) only rare variants and 3) both rare and common variants. The genotype data were 
selected from the NHLBI’s Exome Sequencing Project (ESP) with 3,248 individuals of 
European origin, which were then used to generate a population of 1,000,000 individuals.   
We first study the SNP-based simulations. The genotype-phenotype network consisted of 
two parts. The first part was the phenotype network that was modeled by a DAG. The second 
part was the connections between the genotypes and phenotypes in which the genotypes were 
directed to the phenotypes. We randomly generated a genotype-phenotype network structure 
(Figure S4). The parameters ij in the SEMs for modeling phenotype sub-network were 
generated from a uniformly distributed random variable over the interval (0.5, 1) or (-1,-0.5) if 
an edge from node j  to node i was presented in the phenotype sub-network; otherwise ij =0.  
Similarly, the parameters ijB  in the SEMs for modeling the direction from the genotype (SNP) 
node j  to the phenotype node i were generated from a uniformly distributed random variable 
over the interval (0, 1) or (-1,0) if an edge from node j  to node i was presented in the genotype-
phenotype network, otherwise 0ijB .  The indicator variables for coding genotypes of the SNP 
were as previously described. The true structure of the genotype-phenotype network used for 
simulation was plotted in Figure S4 where no cycles were presented. Using the pre-determined 
network structure, the assumed parameters in the structural equations, we generated the 
phenotypes by the model: 11   XBY , where )01.0,0(~ IN  , and X is a matrix of 
indicator variables for coding genotypes. 
Simulations were repeated 1,000 times. Five-fold cross validation was used to determine 
the penalty parameter    that was then employed to infer the network while running power 
simulations. Two measures: the power of detection (PD) and the false discovery rate (FDR) were 
used to evaluate the performance of the algorithms for identification of the network structures. 
Specifically, let tN be the total number of edges among 1000 replicates of the network and tNˆ  be 
the total number of edges detected by the inference algorithm, trueN be the total number of true 
edges detected among simulated network and FalseN  be the false edges detected among tNˆ . Now, 
the power of detection (PD) is defined by 
t
True
N
N
ˆ
and false discovery rate (FDR) is defined by 
t
False
N
N
ˆ
 .  
In the SNP-based simulations we compared the performance of the proposed sparse 2-stage 
SEM (S2SEM) method with the QTLnet algorithm22 which can be used for joint inference of 
causal network and genetic architecture for correlated phenotypes. Figure 1 shows the power of 
two methods: S2SEM and QTLnet for detecting the structure of the genotype (common variants, 
rare variants and both common and rare variants)– phenotype network as a function of sample 
size, assuming the network sparsity level 008.0 .  We observed three features. First, when the 
network was sparse (the sparsity level 008.0 ) the power of S2SEM in all three cases was the 
highest among three methods. Second, the power of the two methods to detect the structure of 
the networks with the common variants was the highest, followed by the both common and rare 
variants. The power of two methods to detect the structure of the network with the rare variants 
was the lowest. Third, in general, the power increased when the sample sizes increased. To fully 
evaluate the performance of the two methods, we also presented Figure 2 showing the FDR for 
detection of the structure of the networks as a function of sample sizes. It was clear that the FDR 
of the S2SEM in all three cases was lower than QTLnet method. The FDR of two methods to 
detect the structure of the networks with the common variants was the lowest, followed by the 
both common and rare variants. The FDR of two methods to detect the structure of the network 
with the rare variants was the highest. However, the false discovery rates for these two methods 
and in three cases were larger than 0.1 even the sample sizes reached 3,000, and it is larger than 
0.3 in the rare variants case. 
Figure 1 showed that the power of the variant by variant tests for identifying the network 
structure with the rare variants was low. To increase the power, we develop functional SEMs 
(FSEMs) for network analysis using a genomic region or gene as a unit of analysis. To evaluate 
this strategy, we present Figures 3 and 4 to compare the power and FDR of the gene-based 
FSEMs and the SNP-based SEMs for detection of the network structures. Since the original 
papers for QTLnet22 did not develop the gene-based statistics, in Figures 3 and 4 we did not 
present the results of QTLnet algorithm. We observed that in all three cases: common, rare and 
both common and rare variants, the gene-based FSEM had much higher power and smaller FDR 
than the SNP-based SEMs. It is interesting to observe that even if for the rare variants the gene-
based method can reach the power as high as 85% when sample sizes were larger than 3,000. 
Application to Real Data Examples 
To evaluate its performance, we applied the sparse functional SEMs with a gene as a unit 
of analysis to a sample of 1,011 European-Americans (EA) with complete exome sequencing 
(total of 1,861,447 common and rare variants, 18,025 genes, of which, 5,288  genes were 
mapped to 259 pathways downloaded from the KEGG database) and 11 phenotypes: high 
density lipoprotein cholesterol (HDL), low density lipoprotein cholesterol (LDL), triglyceride 
(Trig) and total cholesterol (TotChol), fast glucose, systolic blood pressure (SBP), diastolic 
blood pressure, body mass index (BMI) , fastinsulin, Fibrinogen, and platelet count (PLATELET)  
(no missing phenotype data). Inverse rank normal transformation of the phenotypes was used in 
the analysis.    
The analysis consisted of two stages. At the first stage, the sparse functional SEMs were 
applied to each of the 259 pathways and 11 phenotypes to infer genotype-phenotype networks. 
The remaining 12,737 genes which were not mapped to KEGG pathways were divided into 100 
groups according to the order of chromosomes. Again, the sparse functional SEMs were applied 
to each group of genes and 11 phenotypes. We identified 1,789 genes with P-values for testing 
path coefficients < 0.05 from the analysis at the first stage. To dissect pleiotropic genetic 
structure, at the second stage, we select 142 genes that were connected with more than one 
phenotype for further analysis. The sparse functional SEMs were applied to the selected 142 
genes and 11 phenotypes to infer genotype-phenotype networks. To improve the accuracy of 
estimation, a stability selection procedure was used to infer the structure of the network. In other 
words, we randomly resampled data and estimated the genotype-phenotype networks 100 times. 
We only selected arrows when their P-values for testing the path-coefficients were less than 0.05 
and they were present in the estimated network more than 80 times, i.e., the probability for each 
arrow to be selected was more than 0.8.  We identified a genotype-phenotype network with 137 
genes directly connected to 11 phenotypes and 341 edges. 114 genes out of 137 genes showed 
pleiotropic genetic effects. The results were presented in Figure 5. We observed that the most 
causal relationships among phenotypes had P-values < 
710  and stability ~1. This showed that 
the inference about phenotype sub-network is highly reliable. We also observed that large 
proportion of the edges in the phenotype network had two directions. This demonstrated that the 
SEMs had limitations for inferring causal networks.   
     We observed that PIK3R5 directly affected 7 phenotypes, HS1BP3 directly affected 5 
phenotypes, 11 genes directly affected 4 phenotypes, and 33 genes directly affected 3 phenotypes 
and remaining 102 genes directly affected 2 phenotypes. To assess the roles of path analysis in 
detecting genetic pleiotropic effects, we presented Table 1 that summarizes the P-values of 3 
genes that affecting more than 4 phenotypes for path coefficients, the marginal effects of single 
and multiple traits (simple regression and multiple regression), and the minimum of P-values 
derived from principal component analysis (PCA) based regression. Table 1 showed that the 
most P-values for path coefficient were less than that for the marginal effect of corresponding 
single trait.  Estimation of the marginal genetic effect of single trait only explores information of 
the target trait and genetic variants. However, estimation of the path coefficient uses information 
of all the relevant traits and genetic variants. This implies that path analysis has higher power to 
detect genetic risk variants than the traditional marginal analysis.  From Table 1 we also 
observed that in general, each gene had at least one path with P-value for path coefficient was 
less or close to that for marginal effects of multiple relevant traits or their PCA analysis.  Table 
S2 summarizes the results for all the 13 genes that connected to more than 4 phenotypes. 
    SEMs provide a powerful tool to distinguish four types of effects: direct, indirect, total and 
marginal (estimated by a simple regression) effects. Table S3 summarized the direct, indirect, 
total and marginal effects of one variable (phenotype or gene) that was referred to as the causal 
on another variable (phenotype) that was referred to as outcome in Table S3, for all 11 
phenotypes and 137 genes in the Figure 5. Investigating each type of effect allows a more 
comprehensive understanding of the relationship between variables.  
     Table S3 listed the total 1,414 pairs of causal relations between variables. We observed 343 
(24.3%) pairs of relations with direct effects, 1,283 (90.7%) pairs of relations with indirect 
effects and 212 (15%) pairs of relations with both direct and indirect effects (Table 2 showed 
examples of pairs with both direct and indirect effects). This implied that the most effects are 
indirect effects due to mediation. In the quantitative trait locus (QTL) analysis, we often identify 
QTL by testing association of the marginal effect with the single trait. The SEMs provide 
complimentary information about path coefficients. In Table 3 we listed 25 tests in which the P-
values for testing path coefficients were smaller than that for testing the marginal effects 
(coefficient of SRG) and 25 tests in which the P-values for testing marginal effects were smaller 
than that for testing the path coefficients. This showed that using SEMs for path analysis will 
discover additional QTLs that may be missed by marginal association analysis. In theory, the 
total effect of the causal X on outcome Y is equal to the summation of the product of the path 
coefficients  along all possible paths between X and Y .34 In the previous section, the total effect 
is defined as the coefficient 
XParentYX .
 of X  in the linear regression of Y on X and its parent set. 
Let xParentZ  . The total effect ZYX .  can be expressed by
34 
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 .         (19) 
Since causal relations between SNPs do not exist, any SNP does not have its parent, i.e., 
the set Z  is empty. Therefore, for the SNP or gene X , we have YXZYX  . . For example, 
the estimator of the direct effect of gene MET on the phenotype SBP was -0.0596. MET also had 
path MET DBPSBP. The indirect effect of MET on SBP was 0376.0605.00621.0  . 
Thus, the total effect of MET on SBP was -0.022. The marginal effect YX  of MET on SBP 
estimated by SRG was -0.0212. The total effect of MET on SBP estimated from Figure 5 was 
close to the marginal effect of MET on SBP.  This example showed that if the causal 
relationships among the variables were completely captured by a DAG, the total effect and 
marginal effect were almost equal. Therefore, in the genotype-phenotype estimation process, we 
can use the relationship between the total and marginal effects to check whether the causal 
relationship modeled by a DAG is complete.  
Multiple SNPs within a gene jointly have significant genetic effects, but individually 
each SNP make mild contributions to the phenotype variation. Table 4 listed P-values of 22 
SNPs in 7 genes for testing the path coefficients. We observed that single SNP made only a mild 
contribution to the direct effect, the multiple SNPs made significant contributions to the 
phenotype variation. This showed that the gene-based genotype-phenotype inference had higher 
power than the single SNP-based genotype-phenotype inference.  
     Since the most existing methods for genotype-phenotype network estimation only take a 
single SNP as a variable (unite of analysis) and cannot take a gene as a unite of analysis, next we 
illustrate the application of the sparse two stage multivariate SEMs (S2SEM) for inference of 
genotype-phenotype network using SNPs and compared their results with that of QTL-driven 
phenotype network method (QTLnet)22. The number of SNPs in 137 genes was 5,482. Due to the 
limitation of the size of the genotype-phenotype network which the sparse multivariate SEMs 
can estimate, from 137 genes in Figure 5 we selected 45 genes that were  reported to be associated 
with the 11 phenotypes in the analysis or other cardiovascular disease (CVD) related phenotypes in the 
literature. A total of 1,993 SNPs in the 45 genes (248 common and 1,745 rare SNPs) were included in the 
analysis.   
     The gene-based genotype-phenotype network with 55 nodes (11 phenotypes and 44 genes) 
and 110 edges estimated using the selected 45 genes and the FSEM method was shown in Figure 
6.  S2SEM can also be used to estimate gene-based genotype-phenotype network. The 
procedures were as follows. At the first stage, S2SEM method and all 1,993 SNPs were used to 
estimate the genotype-phenotype network (Figure 7) where a gene was connected to a phenotype 
if the minimum of P-values for the coefficients of all the paths connecting SNPs within a gene 
and a phenotype was less than 0.05. At the second stage, we used Bonferroni correction to adjust 
P-values for multiple tests. In Figure 8, we plotted the estimated genotype-phenotype network 
with 17 nodes (11 phenotypes and 6 genes) and 22 edges using the selected 45 genes and the 
gene-based S2SEM method where a gene was connected to a phenotype if the Bonferroni 
correction adjusted P-values for path coefficients connecting gene and phenotype was less than 
0.05. Figures 6 and 8 showed that the gene-based FSEM method can identify much more genes 
influencing phenotypes than the gene-based S2SEM method.  
   Next we study the SNP-based genotype-phenotype network estimation using the S2SEM 
method. In other words, we connected genes to the phenotypes using the minimum of P-values 
for the coefficients of all the paths that connect SNPs within a gene and a phenotype without 
Bonferroni correction.    Figure 7 plotted the estimated genotype-phenotype network with 42 
nodes (11 phenotypes and 31 genes) and 78 edges using S2SEM method and 1,993 SNPs in the 
45 genes. The path coefficients and P-values (<0.05) for the path coefficients of the edges 
connecting the SNPs in the gene to the phenotypes were summarized in Table S4.  In Figure S5, 
we plotted the estimated genotype-phenotype network with 13 nodes (10 connected phenotypes, 
one isolated phenotype and 2 genes) and 20 edges using QTLnet method. In Table S5, we listed 
the edges of the estimated network which connect the genes and phenotypes using QTLnet 
method.  While the QTLnet method only identified two genes: LBP connected to the phenotypes 
TRIGS and TOTCHOL, and DOCK1 connected to the phenotype HDL, the SNP-based and 
gene-based S2SEM method, respectively,  discovered 31 and 6 genes connected to phenotypes. 
These results showed that all proposed SEM methods including FSEM, gene-based and SNP-
based S2SEM methods outperform the QTLnet method.   
Similar to the gene-based FSEM method, we observed several remarkable features from these 
results obtained by the S2SEM method. First, we observed three SNPs that showed pleiotropic 
genetic effects (rs138251768 in the gene ADAMTS19 effected SBP and DBP, rs116623954 in the 
gene CNIH3 affected FASTINSULIN and FIBRINOGEN, rs13223756 in the gene MET affected 
SBP and DBP). Second, multiple SNPs in the same gene affected the same phenotype. Three 
SNPs: rs754555, rs754554 and rs754553 in the gene DFNA5 jointly affected BMI, two SNPs: 
rs11017658 and rs61758438 in the gene DOCK1 jointly affected SBP. Third, the pleiotropic 
effects of the gene were due to different SNPs. The SNPs: rs564665 and rs141647150 in the gene 
DAB1 affected phenotypes DBP and FASTGLUCOSE, respectively; the SNPs: rs376043577 and 
rs3731878 in the gene IHH affected BMI and PLATELET COUNT, respectively; SNPs 
rs2232585 and rs2232605  in the gene LBP affected FIBRINOGEN and PLATELET COUNT, 
respectively. SNPs rs2305610, rs372123385 and rs17027957 in the gene OSBPL10 affected BMI, 
DBP and FIBRINOGEN, respectively; three SNPs: rs144082896, rs140962261 and rs11547635 
in the gene SYN3 affected TRIGS, SBP and FASTINSULIN, respectively. You can find more 
examples from Tables S4 and S5. Due to space limitation, they are omitted here. 
   In summary, we jointly estimated genetic architecture and phenotype network with 137 genes 
that were significantly connected to phenotypes. A total of 45 genes out of 137 genes were 
reported to be associated with 11 phenotypes or CVD related phenotypes, Table S6 summarized 
the results of the reported 45 genes and their associated phenotypes. For the reported phenotypes, 
6 phenotypes are from the analyzed 11 phenotypes. According to Figure 5, Gene SMC2 was 
connected with phenotypes: BMI, HDL and FIBRINOGEN. It was reported associated with 
HDL and BMI,43,44 and also related with respiratory function and Echocardiography.45,46 Gene 
RNF157 was connected with HDL, and it was reported associated with blood pressure47 and 
HDL.43 The other pairs of association for these 6 phenotypes were found through indirect paths 
from Figure 5. For example, gene DAB1, DFNA5 and DOCK1 were reported associated with 
LDL44, and there are indirect path from these genes to LDL according to Figure 5. From these 
results we can summarized that our gene-based functional SEMs (FSEM) has a rather high 
power to detect genetic pleiotropic effects, and it also provide a tool to decompose the effects 
into direct and indirect effects. 
Discussion 
Alternative to the standard marginal models for genetic association analysis of multiple 
correlated phenotypes, we have developed sparse SEMs and sparse FSEMs as a statistical 
framework for joint analysis of genetic architecture and causal phenotype network, which may 
emerge as a new generation of genetic analysis of multiple phenotypes exploring the causal 
network structures of the phenotypes. To facilitate using SEMs as a new paradigm for genetic 
analysis of multiple phenotypes, several issues have been addressed in this paper. 
The first issue is to develop a unified framework for joint analysis of genetic architecture 
and causal phenotype network with both GWAS and the NGS data. The traditional multivariate 
SEMs can be applied to infer genotype-phenotype network with common variants, but are 
difficult to deal with rare variants. To overcome this limitation, we extend the multivariate SEMs 
to functional SEMs where exogenous genotype profiles across a genomic region or a gene are 
represented as a function of the genomic position for genetic analysis of multiple quantitative 
traits. In other words, we extend the variant-based genotype-phenotype network analysis to gene-
based genotype-phenotype network analysis. 
The second issue is how to develop statistical methods for jointly inferring genetic 
architecture and casual phenotype network structure. There is increasing consensus that the 
structure of the network in nature is sparse. However, the traditional estimation methods for the 
SEMs do not take the sparsity presented in the network into account. To solve this problem, we 
developed sparse SEMs and sparse functional SEMs to automatically incorporate the sparse 
condition into the estimation process. The widely used estimation method for the SEMs is the 
maximum likelihood method. However, the penalized maximum likelihood method and 
coordinate descent algorithms are not scalable to SEMs of high dimension. To overcome this 
limitation, we develop the ADMM-based sparse two-stage least square estimation method for the 
structure and parameter estimation of the SEMs. Our experience showed that the newly 
developed ADMM-based sparse two-stage least square estimation methods can infer networks 
with hundreds of nodes.  
The third issue is the true structure discovery. An essential problem for the genotype-
phenotype network analysis is to accurately estimate the network structure. By large scale 
simulations we showed that the true network structure can be accurately recovered with high 
probability. We also compared the performance of the sparse two-stage least square estimate 
methods with the QTLnet method. We demonstrated that for all the three cases (common, rare 
and both common and rare variants) our sparse two-stage SEMs (S2SEM) outperformed QTLnet 
method. Since the gene-based version of QTLnet method has not been developed we only 
compared the power and false discovery rates of the variant-based SEMs and gene-based 
functional SEMs. We found that for all spectrums of allele frequencies (common, rare and both 
common and rare variants) the gene-based functional SEMs substantially outperformed the 
variant-based multivariate SEMs.  
The fourth issue is how to distinguish four types of effects: direct, indirect, total and 
marginal effects. The current paradigm for genetic association analysis of multiple phenotypes is 
genetic marginal analysis in which the effects of the genetic variants on the phenotypes are 
estimated by regressing phenotypes on the genetic variants. This paradigm is unable to unravel 
the structure of the genotype-phenotype network and to estimate direct, indirect and total effects 
of the genetic variants on the phenotypes. The direct, indirect and total genetic effects provide 
valuable information for dissecting genetic structure of complex traits. We developed sparse 
SEMs and FSEMs as a causal inference tool to estimate direct, indirect and total genetic effects 
in addition to estimating marginal genetic effects. We observed that the most effects were 
indirect effects due to mediation. In traditional QTL analysis, we often identify QTL by testing 
association of the marginal effect with the single trait. The FSEMs and SEMs provide 
complimentary information about path coefficients. Interestingly, we found that many P-values 
for testing path coefficients were smaller than that for testing the marginal effects. This 
demonstrated that only using marginal association analysis we might miss identification of many 
significant QTLs. 
The fifth issue is how to solve the large genotype-phenotype networks with up to 
hundreds of nodes or genes. A key to the large network inference is computation efficiency of 
the algorithms. Two strategies were employed to solve this problem. The first strategy was to 
reduce the dimension of data using functional data analysis. We first expand the genotype 
profiles in a genomic region (gene) in terms of orthonormal eigenfunctions. Genetic information 
across all variants in the genomic region including all single variant variation and their linkage 
disequilibrium is compressed into functional principal component scores. We use genetic 
information compressed into functional principal component scores to infer genotype-phenotype 
networks. The second strategy is to use ADMM algorithms to optimally solve the sparse SEM 
problem. The widely used algorithms for sparse SEMs are coordinate descent algorithms 
borrowed from the lasso originally designed for the sparse linear regression. The ADMM 
algorithms are parallel and efficient. Their convergence rates are fast. The ADMM algorithms 
allow inferring networks with hundreds or even thousands of nodes.  
Major limitation of the SEMs for joint inference of genetic architecture and causal 
phenotype networks is the presence of two directions associated with one edge in the estimated 
network, which leads to a cyclic graph. To remove the cycles from the graph we need to strictly 
enforce the global constraint that the graph structure has to be acyclic. Such problems are often 
casted into a combinatorial optimization problem. We rank graph structures via a scoring metric 
that measure how well the DAG models fit the data. Combinatorial optimization algorithms are 
then used to search the optimal DAG with the best score.48 
Although their application to genome-wide genotype-phenotype network construction is 
difficult due to computational limitations, the SEMs are suitable to the phenome-wide 
association studies where starting phenomics, defined as the unbiased study of a large number of 
phenotypes in a population. We study the complex networks between multiple expressed 
phenotypes and genetic variants.  Since the number of genetic variants in the phenome-wide 
association is quite limited and hence the size of the genotype-phenotype network is limited, the 
required computational time of construction of genotype-phenotype networks using SEMs is in 
the range the current computer system can reach. Advances in biosensors and sequencing 
technologies generate large amounts of phenotype and genetic data. SEMs and causal inference 
may emerge as a new paradigm of genetic studies of complex traits. The main purpose of this 
paper is to stimulate discussions about what are the optimal strategies to facilitate the 
development of a new generation of genetic analysis. We hope that our results will greatly 
increase the confidence in joint inference of genetic architecture and causal phenotype networks.  
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Titles and Legends to Figures 
Figure 1. The power of two methods: S2SEM and QTLnet for detecting the structure of the 
genotype (common variants, rare variants and both common and rare variants) – phenotype 
network as a function of sample size, assuming the network sparsity level 008.0 .  
Figure 2. The false discovery rates of two methods: S2SEM and QTLnet for detecting the 
structure of the genotype (common variants, rare variants and both common and rare variants) – 
phenotype network as a function of sample size, assuming the network sparsity level 008.0 .  
Figure 3. The power curves of the S2SEM with the SNP-based and gene-based methods for 
detecting the structure of the genotype (common variants, rare variants and both common and 
rare variants) – phenotype network as a function of sample size, assuming the network sparsity 
level 008.0 .  
Figure 4. The false discovery rates of the S2SEM with the SNP-based and gene-based methods 
for detecting the structure of the genotype (common variants, rare variants and both common and 
rare variants) – phenotype network as a function of sample size, assuming the network sparsity 
level 008.0 .  
Figure 5.  A genotype-phenotype network consisted of 137 genes and 11 phenotypes, 114 genes 
of them showed pleiotropic genetic effect. The nodes in yellow color represented the phenotypes, 
the nodes in light red color represented genes influencing phenotype variation, the nodes in the 
red color represented genes that are reported to be associated with 11 phenotypes or 
cardiovascular diseases phenotypes, the black arrows indicated the causal relations between 
phenotypes, the blue arrows indicted the contribution of the gene to one phenotype.  
Figure 6. A genotype-phenotype network consisted of 44 genes and 11 phenotypes constructed 
using FSEM from 45 genes. Nodes and edges are the same as described in Figure 5. 
Figure 7. A genotype-phenotype network consisted of 31 genes and 11 phenotypes constructed 
using SNP-based S2SEM method from 1993 SNPs of 45 genes. Nodes and edges are the same as 
described in Figure 5. 
Figure 8. A genotype-phenotype network consisted of 6 genes and 11 phenotypes constructed using the 
gene-based S2SEM method from 1993 SNPs of 45 genes where a gene was connected to a phenotype if 
the Bonferroni correction adjusted P-values for path coefficients connecting gene and phenotype was less 
than 0.05. Nodes and edges are the same as described in Figure 5. 
 
 
 
 
 
 
 
 
 
 
 
Appendix A 
Alternating Direction Method of Multipliers for Sparse SEMs 
The optimization problem (7) can be further reduced to 
.0   subject to
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The alternating direction method of multipliers (ADMM) consists of the iterations: 
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Solving minimization problem (A6), we obtain 
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 The optimization problem (A7) is non-differentiable. Although the first term in (A7) is not 
differentiable, we still can obtain a simple closed-form solution to the problem (A7) using 
subdiffenrential calculus.37   Let j be a generalized derivative of the j -th component 
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Appendix B 
Estimation of Parameters in the Sparse Structural Functional Equation Models for the 
Genotype-Phenotype Networks 
Assume that the sparse SFEMs are given by 
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For each genomic region or gene, we use functional principal component analysis to calculate 
principal component function.14 We expand kjtxij ,...,2,1),(  in each genomic region in terms of 
orthogonal principal component functions: 
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where jjl Llkjt ,...,1,,...,1),(  are the l -th principal component function in the j -th genomic 
region and ijl are the functional principal component scores of the i -th individual. Using the functional 
principal component expansion of )(txij , we obtain 
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and ,Y and E be defined as before. 
In matrix form, equation (B4) can be rewritten as 
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which has the same form as the equation (2) has.  
If we consider only one genomic region or gene, the matrices   and B will be reduced to 
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If we take functional principal component scores as predictors, the models and algorithms for 
network structure and parameter estimation will be similar to that discussed in Appendix A. 
Specifically, the i -th equation is given by 
0 iii eBY  , 
which can be rewritten as  
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Then, the sparse SFEMs are transformed to 
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Finally, ADMM algorithms are given by 
Algorithm: 
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Carry out steps 2,3 and 4 until convergence 
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Table 1. P-values for the path coefficient, mariginal effects of single trait and multiple traits, and minimum of P-values 
from PCA analysis (example of 3 genes that connected to more than 4 phenotypes). 
Outcome Causal Stability P-value for path 
coefficient 
P-value (Single 
Trait Marginal ) 
Min (P-value) 
PCA 
P-value (Multiple 
Traits Marginal) 
      1.44E-03 1.57E-03 
SBP PIK3R5 1 8.38E-05 9.25E-02   
DBP PIK3R5 1 1.20E-03 7.62E-02   
TRIGS PIK3R5 0.9 5.59E-03 1.07E-01   
FASTGLUCOSE PIK3R5 0.9 1.31E-02 2.01E-01   
BMI PIK3R5 0.88 1.63E-02 2.61E-01   
FASTINSULIN PIK3R5 0.92 3.00E-02 7.94E-01   
HDL PIK3R5 0.81 3.84E-02 2.39E-01   
          2.17E-04 2.43E-04 
DBP HS1BP3 0.96 1.21E-04 1.58E-01   
HDL HS1BP3 0.98 6.78E-04 8.15E-04   
SBP HS1BP3 0.87 6.08E-03 9.10E-01   
BMI HS1BP3 0.94 1.71E-02 1.91E-01   
FASTGLUCOSE HS1BP3 0.91 1.99E-02 5.95E-02   
          4.79E-04 5.24E-04 
DBP ABCC9 1 5.30E-06 6.49E-02   
SBP ABCC9 0.94 2.56E-04 4.63E-01   
FASTINSULIN ABCC9 0.95 2.71E-03 2.10E-03   
FIBRINOGEN ABCC9 0.96 5.52E-03 7.71E-02   
 
 
 
Table 2. An example of 20 pairs of variables that had both direct and indirect effects. 
Outcome Causal Direct Effect Indirect Effect Total Effect Marginal Effect  
BMI ATP6V1G3 -0.5701  0.0107  -0.5594  -0.5360  
BMI C12orf77 -1.3704  -0.2745  -1.6449  -1.7371  
BMI EPHB2 -0.2627  0.0544  -0.2083  -0.2017  
BMI PIK3R5 0.0631  -0.0119  0.0512  0.0541  
BMI RPS21 0.7630  0.0123  0.7754  0.8282  
DBP CHUK 0.0553  -0.0355  0.0199  0.0213  
FASTGLUCOSE C11orf49 0.6186  0.0146  0.6332  0.5846  
FASTGLUCOSE C12orf77 -1.2863  -0.2366  -1.5228  -1.5121  
FASTGLUCOSE PIK3R5 0.0674  -0.0133  0.0541  0.0530  
FASTGLUCOSE TAF5L 0.2911  0.0196  0.3107  0.2942  
FASTINSULIN SFMBT2 0.2874  -0.0898  0.1975  0.1930  
FIBRINOGEN FAM120AOS -0.1550  0.0033  -0.1516  -0.1597  
HDL CREBBP 0.1168  -0.0176  0.0992  0.1097  
HDL ITPR2 0.0946  -0.0542  0.0404  0.0434  
LDL TOTCHOL 0.9458  0.0161  0.9619  0.9398  
SBP AQPEP -0.0425  0.0282  -0.0143  -0.0156  
SBP CHUK -0.0595  0.0335  -0.0261  -0.0272  
SBP MET -0.0596  0.0376  -0.0220  -0.0212  
 
 
 
 
 
 
Table 3. 25 pairs of P-values for testing path coefficients and marginal effects, respectively. 
  P-value   P-value 
Outcome Causal Path Coeff Marginal Effect Outcome Causal Path Coeff Marginal Effect 
DBP ABCC9 5.30E-06 6.49E-02 HDL ITFG2 4.42E-04 1.98E-05 
DBP TRPM4 9.51E-06 7.24E-02 TRIGS ST3GAL3 2.21E-04 1.16E-04 
BMI POLR2F 1.14E-05 3.93E-04 PLATELET CRTAP 3.79E-04 1.58E-04 
PLATELET TRMT61B 1.17E-05 1.02E-04 HDL ASCC2 5.58E-04 1.99E-04 
SBP CHUK 1.44E-05 1.76E-01 FASTGLUCOSE PTH1R 5.72E-03 2.00E-04 
DBP QARS 2.00E-05 8.82E-03 PLATELET PDE1B 4.61E-04 3.02E-04 
PLATELET TCOF1 2.10E-05 1.36E-02 HDL HS1BP3 6.78E-04 3.56E-04 
FIBRINOGEN SMC2 2.33E-05 1.06E-03 TRIGS ITFG2 7.32E-03 3.81E-04 
HDL DRGX 3.20E-05 3.22E-04 HDL NT5E 3.26E-02 5.86E-04 
DBP CHUK 3.33E-05 2.88E-01 HDL EPHB2 4.30E-03 6.33E-04 
FIBRINOGEN C11orf49 4.58E-05 5.10E-05 FIBRINOGEN CEP170B 4.71E-03 7.04E-04 
LDL LARP7 4.58E-05 3.33E-01 DBP PIDD 1.51E-03 7.53E-04 
LDL CD7 5.16E-05 7.68E-02 HDL HBEGF 3.43E-03 8.44E-04 
FIBRINOGEN CRK 8.66E-05 1.45E-03 FASTGLUCOSE RNF122 4.29E-02 9.17E-04 
PLATELET MYLK 9.80E-05 1.14E-03 DBP AC053503.11 5.62E-03 1.08E-03 
SBP STX3 1.07E-04 1.60E-03 FIBRINOGEN CNIH3 1.07E-02 1.13E-03 
FASTINSULIN MPO 1.09E-04 3.22E-03 BMI NFIC 1.74E-03 1.15E-03 
FIBRINOGEN OSBPL10 1.18E-04 3.99E-03 FASTGLUCOSE IHH 4.66E-02 1.17E-03 
SBP ST3GAL3 1.56E-04 1.99E-03 FASTGLUCOSE ARHGAP27 1.87E-03 1.30E-03 
HDL LARP7 1.60E-04 3.31E-02 SBP SLC18A2 1.42E-02 1.44E-03 
HDL SOX13 1.60E-04 6.78E-03 BMI QKI 1.93E-03 1.61E-03 
PLATELET SH3TC1 2.18E-04 1.25E-02 FASTGLUCOSE SLC38A1 1.44E-02 1.65E-03 
SBP ABCC9 2.56E-04 4.63E-01 SBP ZNF740 4.68E-03 1.81E-03 
BMI DCDC2B 2.64E-04 8.70E-02 TRIGS ADAMTS19 2.31E-02 1.82E-03 
SBP TRPM4 2.71E-04 2.19E-01 PLATELET GAK 1.54E-02 2.02E-03 
 
 
 
 
 
 
 
  
Table 4. P-values of 22 SNPs in  7 genes for testing path coefficients. 
Phenotype    P-value  Testing Path Coef 
  Gene Chr SNP Position Gene SNP 
FASTGLUCOSE SEMA3B 3 50310922 5.98E-06 6.41E-05 
FASTGLUCOSE DNAJC16 1 15873386 1.09E-05 5.62E-03 
FASTGLUCOSE DNAJC16 1 15874961  3.61E-03 
FASTGLUCOSE DNAJC16 1 15905501  3.94E-02 
DBP OBSCN 1 228404668 1.48E-05 8.81E-02 
DBP OBSCN 1 228461187  9.96E-02 
DBP OBSCN 1 228482028  9.68E-02 
DBP OBSCN 1 228496066  8.61E-02 
DBP OBSCN 1 228503711  6.52E-04 
DBP OBSCN 1 228565208  2.66E-03 
DBP OBSCN 1 228565445  8.28E-02 
HDL SOX13 1 204085609 4.31E-05 2.45E-02 
HDL SOX13 1 204092129  9.14E-04 
HDL SOX13 1 204094963  9.40E-02 
HDL SOX13 1 204095220  3.56E-02 
HDL SOX13 1 204095280  3.79E-02 
HDL SRRM5 19 44099538 4.74E-05 6.37E-02 
HDL SRRM5 19 44111890  2.21E-05 
FIBRINOGEN SLC45A4 8 142225990 1.63E-04 3.97E-02 
FIBRINOGEN SLC45A4 8 142226108  1.61E-02 
FIBRINOGEN SLC45A4 8 142228909  8.87E-04 
FIBRINOGEN LHFPL2 5 77784738  5.95E-06 4.21E-06 
 
 
 
  
 
 
 
 
 
 
 




